Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ProQR Therapeutics N.V. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
PRQR
Nasdaq
2830
www.proqr.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ProQR Therapeutics N.V.
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22%
- May 14th, 2026 6:25 am
Kamada (KMDA) Misses Q1 Earnings and Revenue Estimates
- May 13th, 2026 6:15 am
ProQR Announces First Quarter 2026 Operating and Financial Results
- May 12th, 2026 5:00 am
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
- May 11th, 2026 6:00 am
Earnings Preview: ProQR (PRQR) Q1 Earnings Expected to Decline
- May 7th, 2026 8:00 am
3 Promising Penny Stocks With Market Caps Up To $600M
- May 6th, 2026 12:05 pm
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
- May 4th, 2026 6:00 am
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates
- Apr 30th, 2026 3:30 pm
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
- Apr 30th, 2026 6:00 am
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
- Apr 8th, 2026 2:00 pm
ProQR Therapeutics Unveils New RNA Editing Programs; AX-0810 Phase 1 Target Data Due This Quarter
- Apr 8th, 2026 10:05 am
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
- Apr 8th, 2026 6:00 am
April 2026 Penny Stock Highlights
- Apr 3rd, 2026 12:05 pm
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
- Mar 29th, 2026 4:15 am
Growing Optimism About ProQR Therapeutics (PRQR)’s RNA Editing Platform and Future Clinical Catalysts
- Mar 25th, 2026 1:29 pm
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
- Mar 25th, 2026 6:00 am
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
- Mar 12th, 2026 8:15 am
ProQR: Q4 Earnings Snapshot
- Mar 12th, 2026 7:18 am
ProQR Announces Year End 2025 Operating and Financial Results
- Mar 12th, 2026 5:00 am
Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates
- Mar 11th, 2026 6:15 am
Scroll